English
Segment disclosures
Company overviewPetros Pharmaceuticals, Inc.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
4 dimension combinations 70 retained observations 21 reported periods
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Operating Segments · Medical Device Sales
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=ptpi:MedicalDeviceSalesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 3150752 | USD | 20250331 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 718303 | USD | 20250124 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 2300460 | USD | 20250124 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 806449 | USD | 20240814 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1582161 | USD | 20240814 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 775711 | USD | 20240515 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 3536015 | USD | 20250331 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 748898 | USD | 20250124 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 2770194 | USD | 20250124 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 1009603 | USD | 20240814 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 2021297 | USD | 20240814 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 1011694 | USD | 20240515 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 3257415 | USD | 20240401 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 854343 | USD | 20230814 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 1794744 | USD | 20230814 | Open filing evidence |
Operating Segments · Prescription Medication Sales
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=ptpi:PrescriptionMedicationSalesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 1961291 | USD | 20250331 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 858063 | USD | 20250124 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 2086180 | USD | 20250124 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 615022 | USD | 20240814 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1228115 | USD | 20240814 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 613095 | USD | 20240515 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 2286373 | USD | 20250331 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 925759 | USD | 20250124 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 3416444 | USD | 20250124 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 984408 | USD | 20240814 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 2490686 | USD | 20240814 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 1506278 | USD | 20240515 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 2734639 | USD | 20240401 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 3332173 | USD | 20230814 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 4856941 | USD | 20230814 | Open filing evidence |
Medical Device Sales
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ptpi:MedicalDeviceSalesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-03-31 | 1011693 | USD | 20230515 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 3257415 | USD | 20230331 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 682897 | USD | 20221115 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 2477642 | USD | 20221115 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 854343 | USD | 20220812 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 1794744 | USD | 20220812 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 940401 | USD | 20230515 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 3206221 | USD | 20230331 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 767878 | USD | 20221115 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 2450671 | USD | 20221115 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 807834 | USD | 20220812 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 1682793 | USD | 20220812 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 874959 | USD | 20220516 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 3201971 | USD | 20220331 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 874544 | USD | 20220106 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 2501486 | USD | 20220106 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 633278 | USD | 20210816 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 1626942 | USD | 20210816 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 993664 | USD | 20210514 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 4466506 | USD | 20220106 | Open filing evidence |
Prescription Medication Sales
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ptpi:PrescriptionMedicationSalesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-03-31 | 1506278 | USD | 20230515 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 2734639 | USD | 20230331 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | -2140629 | USD | 20221115 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 2716311 | USD | 20221115 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 3332173 | USD | 20220812 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 4856941 | USD | 20220812 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 1524768 | USD | 20230515 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 4605043 | USD | 20230331 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 1377291 | USD | 20221115 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 6227753 | USD | 20221115 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 1649815 | USD | 20220812 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 4850462 | USD | 20220812 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 3200647 | USD | 20220516 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 6357498 | USD | 20220331 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 2590151 | USD | 20220106 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 4128694 | USD | 20220106 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 740286 | USD | 20210816 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 1538543 | USD | 20210816 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 798257 | USD | 20210514 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 11110660 | USD | 20220106 | Open filing evidence |